Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Iodine Supplementation for the Prevention of Mortality and Adverse Neurodevelopmental Outcomes in Preterm Infants." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431241/all/Iodine_supplementation_for_the_prevention_of_mortality_and_adverse_neurodevelopmental_outcomes_in_preterm_infants.
Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431241/all/Iodine_supplementation_for_the_prevention_of_mortality_and_adverse_neurodevelopmental_outcomes_in_preterm_infants. Accessed February 19, 2025.
Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431241/all/Iodine_supplementation_for_the_prevention_of_mortality_and_adverse_neurodevelopmental_outcomes_in_preterm_infants
Iodine Supplementation for the Prevention of Mortality and Adverse Neurodevelopmental Outcomes in Preterm Infants [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431241/all/Iodine_supplementation_for_the_prevention_of_mortality_and_adverse_neurodevelopmental_outcomes_in_preterm_infants.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants
ID - 431241
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431241/all/Iodine_supplementation_for_the_prevention_of_mortality_and_adverse_neurodevelopmental_outcomes_in_preterm_infants
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -